News

Venomtech is pleased to share with you our success in finding new venom peptides that kill bacteria in potentially novel ways. These are all found in our antibacterial T-VDA. This is currently a leading story on Sky News blueprint-to-tackle-scourge-of-drug-resistance showing a small snap shot of what we do and why it's important.

We are fighting hard to bring these important tools needed to the people that need them to help mitigate the perceived threat of the antibiotic apocalypse.

The tools you need to find novel mechanisms to fight antibiotic resistant bacteria are right here with a full hit to lead support service to get them to the patient ASAP.

Contact us for more information.

We are excited to announce we are six years old. During those six years we have moved through three locations each time getting bigger and better. Now located in the amazing Discovery Park Community. We have shipped venoms to customers far and wide (USA, Europe, India and Australia). But most importantly we have facilitated work in a wide range of drug discovery programmes including new antibiotics, GPCR ligands, Pain therapeutics and Cancer biology. We have also gained a deep understanding of the venoms and the venomous animals (more publications to come). Looking forward we expect to further grow into the cosmetics and personal care fields as well as our global reach in pharmaceutical research.

New pharmacological tools from a haematophagus (Vampire) snail, Colubraria reticulata, have been discovered. these include anaesthetic peptides, haemostasis inhibitors and vasoconstriction modulators see paper. The authors note that fish appear to be semi anaethetised when the snail is in close proximity and this enables the snail to extend it's probosis and collect the fishes blood.

With the domination of classical antibiotics coming to a dramatic end, it is time to find novel sources of antibiotics that circumvent the ability of the bacterial to evolve resistance.

New classes of antibiotics are being found in the venoms of several species. Screening these as you would for other compounds is already yielding promising results.

Find out more on our product page here.